Evidence map›Paper›PMID 28640881›Full record

ArticlePLoS pathogens2017

T3SS effector VopL inhibits the host ROS response, promoting the intracellular survival of Vibrio parahaemolyticus.

Marcela de Souza Santos, Dor Salomon, Kim Orth

Abstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. A critical role forProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Review
  5. Antimicrobial Efficacy of Trifluoro-Anilines AgainstInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Antagonistic effects of actin-specific toxins onbioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marcela de Souza SantosDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Dor SalomonDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.ORCID http://orcid.org/0000-0002-2009-9453
Kim OrthDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.ORCID http://orcid.org/0000-0002-0678-7620

Funding

UT GASTROENTEROLOGY/HEPATOLOGY RESEARCH TRAINING PROGRAMT32DK007745 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Rodney E Infante · 1997 to 2026
$6.8M
Biochemical Characterization of Yersinia Effector YopJ.R01AI056404 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ORTH, KIM · 2003 to 2012
$2.8M
NIAID NIH HHS R01 AI056404NIDDK NIH HHS T32 DK007745
6 · The paper itself

Abstract

The production of antimicrobial reactive oxygen species by the nicotinamide dinucleotide phosphate (NADPH) oxidase complex is an important mechanism for control of invading pathogens. Herein, we show that the gastrointestinal pathogen Vibrio parahaemolyticus counteracts reactive oxygen species (ROS) production using the Type III Secretion System 2 (T3SS2) effector VopL. In the absence of VopL, intracellular V. parahaemolyticus undergoes ROS-dependent filamentation, with concurrent limited growth. During infection, VopL assembles actin into non-functional filaments resulting in a dysfunctional actin cytoskeleton that can no longer mediate the assembly of the NADPH oxidase at the cell membrane, thereby limiting ROS production. This is the first example of how a T3SS2 effector contributes to the intracellular survival of V. parahaemolyticus, supporting the establishment of a protective intracellular replicative niche.

Indexed as

Bacterial ProteinsCaco-2 CellsHost-Pathogen InteractionsHumansMicroscopy, ConfocalReactive Oxygen SpeciesType III Secretion SystemsVibrio InfectionsVibrio parahaemolyticusBacterial ProteinsReactive Oxygen SpeciesType III Secretion Systems

Identifiers

PMID28640881
PMCPMC5481031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.